×
About 733 results

ALLMedicine™ Prosthetic Heart Valves Center

Research & Reviews  359 results

Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about?
https://doi.org/10.1111/jocs.14707
Journal of Cardiac Surgery REFERENCES; Omidi N, Forouzannia SK et. al.

Oct 12th, 2020 - The disturbance in the international normalized ratio (INR) in patients receiving warfarin therapy is of concern. We aimed to evaluate coagulation features in hospitalized patients under warfarin treatment for prosthetic heart valves during the no...

Patient-specific in vitro testing for evaluating TAVR clinical performance- a complemen...
https://doi.org/10.1111/aor.13841
Artificial Organs; Kovarovic BJ, Rotman OM et. al.

Oct 8th, 2020 - Following in vitro tests established for surgical prosthetic heart valves, transcatheter aortic valves (TAV) are similarly tested in idealized geometries- excluding effects that may hamper TAVR performance in situ. Testing in vitro in pulse duplic...

Anticoagulation and antiplatelet therapy in patients with prosthetic heart valves.
https://doi.org/10.1111/jocs.15034
Journal of Cardiac Surgery REFERENCES; Aikins J, Koomson A et. al.

Sep 17th, 2020 - The choice of antithrombotic therapy, anticoagulants or antiplatelets, after prosthetic heart valve replacement or repair, remains a disputed topic in the literature. Antithrombotic therapies are used after heart valve intervention to reduce the r...

Transcatheter mechanical manipulation of obstructed prosthetic mitral valve in an infant.
https://doi.org/10.1017/S104795112000270X
Cardiology in the Young; Arar Y, Hong J et. al.

Sep 3rd, 2020 - Prosthetic valve thrombosis is a serious complication of prosthetic heart valves that typically requires either surgical intervention or systemic thrombolysis. In patients with contraindications to both treatment modalities, options can be limited...

Utility of CT in the diagnosis of prosthetic valve abnormalities.
https://doi.org/10.1111/jocs.14966
Journal of Cardiac Surgery REFERENCES; Velangi PS, Kalra R et. al.

Aug 20th, 2020 - Patients with prosthetic heart valves (PHV) are at an increased risk of endocarditis and dysfunction. Knowledge about the etiology of dysfunction and extent of endocarditis can have distinct treatment implications. Echocardiography has limitations...

see more →

Guidelines  2 results

Characteristics of surgical prosthetic heart valves and problems around labeling: A doc...
https://doi.org/10.1016/j.jtcvs.2019.04.001
The Journal of Thoracic and Cardiovascular Surgery; Durko AP, Head SJ et. al.

May 15th, 2019 - Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labeling of SHVs rendering the comparison of diff...

Computational Fluid Dynamics Assessment Associated with Transcatheter Heart Valve Prost...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095731
Cardiovascular Engineering and Technology; Wei ZA, Sonntag SJ et. al.

Apr 20th, 2018 - The governing international standard for the development of prosthetic heart valves is International Organization for Standardization (ISO) 5840. This standard requires the assessment of the thrombus potential of transcatheter heart valve substitu...

see more →

Clinicaltrials.gov  367 results

Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about?
https://doi.org/10.1111/jocs.14707
Journal of Cardiac Surgery REFERENCES; Omidi N, Forouzannia SK et. al.

Oct 12th, 2020 - The disturbance in the international normalized ratio (INR) in patients receiving warfarin therapy is of concern. We aimed to evaluate coagulation features in hospitalized patients under warfarin treatment for prosthetic heart valves during the no...

Patient-specific in vitro testing for evaluating TAVR clinical performance- a complemen...
https://doi.org/10.1111/aor.13841
Artificial Organs; Kovarovic BJ, Rotman OM et. al.

Oct 8th, 2020 - Following in vitro tests established for surgical prosthetic heart valves, transcatheter aortic valves (TAV) are similarly tested in idealized geometries- excluding effects that may hamper TAVR performance in situ. Testing in vitro in pulse duplic...

Anticoagulation and antiplatelet therapy in patients with prosthetic heart valves.
https://doi.org/10.1111/jocs.15034
Journal of Cardiac Surgery REFERENCES; Aikins J, Koomson A et. al.

Sep 17th, 2020 - The choice of antithrombotic therapy, anticoagulants or antiplatelets, after prosthetic heart valve replacement or repair, remains a disputed topic in the literature. Antithrombotic therapies are used after heart valve intervention to reduce the r...

Transcatheter mechanical manipulation of obstructed prosthetic mitral valve in an infant.
https://doi.org/10.1017/S104795112000270X
Cardiology in the Young; Arar Y, Hong J et. al.

Sep 3rd, 2020 - Prosthetic valve thrombosis is a serious complication of prosthetic heart valves that typically requires either surgical intervention or systemic thrombolysis. In patients with contraindications to both treatment modalities, options can be limited...

Utility of CT in the diagnosis of prosthetic valve abnormalities.
https://doi.org/10.1111/jocs.14966
Journal of Cardiac Surgery REFERENCES; Velangi PS, Kalra R et. al.

Aug 20th, 2020 - Patients with prosthetic heart valves (PHV) are at an increased risk of endocarditis and dysfunction. Knowledge about the etiology of dysfunction and extent of endocarditis can have distinct treatment implications. Echocardiography has limitations...

see more →

News  5 results

FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves
https://www.fda.gov/Drugs/DrugSafety/ucm332912.htm

Comunicado de la FDA sobre la seguridad de los medicamentos: Pradaxa (dabigatrán etexilato mesilato) no se debe usar en pacientes con válvulas protésicas del corazón 1-800-332-1088 1-800-FDA-0178 Fax Report a Serious Problem MedWatch Online Regula...

FDA Drug Safety Communication: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate)
https://www.fda.gov/Drugs/DrugSafety/ucm282724.htm

FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves 12/19/2012 1-800-332-1088 1-800-FDA-0178 Fax Report a Serious Problem MedWatch Online Regular Mail: Use p...

GI Bleeding Linked To Dysfunctional Prosthetic Valves
https://www.medpagetoday.com/cardiology/pci/57243

Apr 7th, 2016 - Action Points Abnormal von Willebrand factor (VWF) levels can indicate the dysfunction of prosthetic heart valves, according to a study, and that condition has in turn been tied to gastrointestinal bleeding acquired from a surgery or transcatheter...

2012 Drug Safety Communications
https://www.fda.gov/Drugs/DrugSafety/ucm287414.htm

Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves 12/19/2012 Serious skin reactions after combination treatment with the Hepatitis C drug Incivek (telaprevir), peginterferon alfa, and ri...

Caring for patients with prosthetic heart valves
https://www.mdedge.com/ccjm/article/93750/cardiology/caring-patients-prosthetic-heart-valves
Monica S. Bettadapur, MD, Brian P. Griffin, MD et. al.

ABSTRACTPatients with prosthetic heart valves require regular examinations and echocardiograms, antithrombotic therapy, and appropriate antibiotic prophylaxis against endocarditis. Physicians must also be on the alert for several uncommon but pote.

see more →